Non-Invasive Blood Glucose Monitoring Devices Market

Future Market Insights

Key Insight

The non-invasive blood glucose monitoring devices market is projected to grow from USD 9.3 billion in 2025 to USD 21.9 billion by 2035, at a CAGR of 8.9%. MIR/NIR (Mid/Near Infrared Spectroscopy) will dominate with a 25.9% market share, while wearable blood glucose monitoring systems will lead the modality segment with a 61.3% share.

September 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Non-Invasive Blood Glucose Monitoring Devices Market

https://www.futuremarketinsights.com/reports/non-invasive-blood-glucose-monitoring-devices-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
The Vanguard Group
Biolinq Inc
CNOGA Medical
Dexcom Inc
DiaMonTech GmbH
GlucoSense Diagnostics
Integrity Applications (GlucoTrack)
Know Labs Inc
MediWise / Occuity Ltd
Medtronic plc
Movano Health
Nemaura Medical Inc
OptiScan Biomedical
OrSense Ltd
RSP Systems
Scanbo Corp
Senseonics Holdings
Verily Life Sciences

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Non-Invasive Blood Glucose Monitoring Devices Market

Key Players

Similar Industry Reports